VIOLET THOMAS: Open Payments
NPI 1376386946 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,782 in 155 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,198 · 2025 $3,782
Food & beverage: $3,748Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 39 | $934 |
| Regeneron Healthcare Solutions, Inc. | 13 | $383 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $333 |
| Novartis Pharmaceuticals Corporation | 11 | $240 |
| GlaxoSmithKline, LLC. | 13 | $229 |
| GENZYME CORPORATION | 10 | $228 |
| Pharming Healthcare, Inc. | 5 | $205 |
| Grifols USA, LLC | 7 | $203 |
| Genentech USA, Inc. | 10 | $185 |
| CSL Behring | 6 | $178 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, BREZTRI, Xolair, RUCONEST, Prolastin-C Liquid, FASENRA.
Industry payments across AL — which companies pay providers there.
